Enjoy complimentary customisation on priority with our Enterprise License!
The allergy immunotherapies market size is forecast to increase by USD 1.19 billion at a CAGR of 9.62% between 2023 and 2028. Allergy illnesses, particularly those affecting the respiratory system due to pollen, air pollution, and unknown pathogens, are on the rise in the US healthcare system. The increasing prevalence of these conditions drives the demand for effective treatments, such as allergy immunotherapies. Technological advances in allergy diagnostics enable earlier identification and treatment, contributing to market growth. Subcutaneous immunotherapy (SCIT) is a promising allergy treatment, offers long-term relief for patients. However, challenges persist, including alcohol consumption's impact on medication efficacy and accessibility issues in the healthcare system. As the US population continues to grapple with these health concerns, the market is poised for significant expansion.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.